Nadine Errington

Nadine Errington currently serves as the Chief Financial Officer at Sapphire since May 2024. Prior to this role, Nadine was the Group Finance Director at Learning Curve Group from April 2023 to May 2024 and at THF Holdings Limited for a brief period in mid-2022. Additionally, Nadine held the position of Finance Director - North with EQUANS UK & Ireland from January to July 2022 and served as Finance Director - Unlicensed Medicines at Clinigen Group from March 2020 to January 2022. The career began at Quantum Pharma, where Nadine progressed through various roles, including Financial Controller and Head of Finance, from November 2012 to January 2022. Earlier experience includes serving as a Senior IFRS Specialist at AltaLink in 2012 and a Manager at KPMG from September 2005 to February 2012.